ArticleCureus2025
Functional and Quality of Life Outcomes in Heart Failure Patients at a Specialized Heart Failure Clinic in Dhaka, Bangladesh.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundManaging heart failure patients in resource-limited settings presents significant challenges, with limited data on quality of life and functional outcomes. This study investigated these outcomes in patients attending a heart failure clinic (HFC) in Dhaka, Bangladesh.
methodsData were analyzed from 454 patients registered between January 2016 and December 2021 at the HFC of the United Hospital Limited, Dhaka, Bangladesh, who had baseline and follow-up data, including left ventricular ejection fraction (LVEF). A multivariable logistic regression model using generalized estimating equations identified predictors of ≥5% LVEF improvement.
resultsPatients averaged 58.4 ± 11.4 years, with 80.4% being male. Median baseline LVEF was 35% (IQR: 30-40). At baseline, 77.3% had heart failure with reduced ejection fraction (HFrEF), 10.1% had heart failure with mid-range ejection fraction (HFmrEF), and 12.6% had heart failure with preserved ejection fraction (HFpEF). LVEF improved in 39.6% of patients, while quality of life improved in 16.1%. Significant predictors of ≥5% LVEF improvement included age (adjusted odds ratio (aOR): 0.97; 95% CI: 0.95-0.99), female sex (aOR: 2.13; 95% CI: 1.21-3.73), history of acute kidney injury (aOR: 0.12; 95% CI: 0.02-0.81), and baseline HFrEF (aOR: 2.90; 95% CI: 1.34-6.26).
conclusionThese findings underscore the need for tailored heart failure management approaches in resource-limited settings that consider patient-specific factors alongside dedicated interventions to improve quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.